サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1413879

バイオマニュファクチャリングにおけるウイルス検出・定量化市場：提供タイプ、技術、用途、エンドユーザー別-2024-2030年世界予測

Biomanufacturing Viral Detection & Quantification Market by Offering Type (Consumables, Instruments, Services), Technology (Enzyme-Linked Immunosorbent Assay, Flow Cytometry, Plaque Assay), Application, End User - Global Forecast 2024-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 194 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
バイオマニュファクチャリングにおけるウイルス検出・定量化市場：提供タイプ、技術、用途、エンドユーザー別-2024-2030年世界予測
出版日: 2024年01月16日
発行: 360iResearch
ページ情報: 英文 194 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

バイオマニュファクチャリングにおけるウイルス検出・定量化市場規模は2023年に26億7,000万米ドルと推計され、2024年には28億9,000万米ドルに達し、CAGR 8.40%で2030年には47億1,000万米ドルに達すると予測されます。

バイオマニュファクチャリングにおけるウイルス検出・定量化の世界市場

主な市場の統計
基準年[2023］ 26億7,000万米ドル
予測年[2024］ 28億9,000万米ドル
予測年 [2030] 47億1,000万米ドル
CAGR（%） 8.4%
Biomanufacturing Viral Detection &Quantification Market-IMG1

バイオ医薬品製造におけるウイルス検出・定量化市場は、バイオ医薬品製造プロセスにおけるウイルス汚染物質の同定・測定のための技術、サービス、ソリューションの開発、生産、商業化に関わる産業とセクターを包括しています。バイオ医薬品研究開発への投資の増加が市場成長に寄与しています。有名な汚染事件を受けて製品の安全性に対する意識が高まり、厳しい規制要件がイントロダクションとして導入されたことが、バイオマニュファクチャリングにおけるウイルス検出・定量化市場の事業成長を後押ししています。しかし、検査コストの高さや規制当局の承認プロセスの複雑さは、中小企業にとって参入障壁となり、市場競争に影響を及ぼす可能性があります。また、複雑なアッセイを実施・解釈するためには高度なスキルを有する人材が必要であるため、市場スペース運営上の課題も増えます。さらに、新規のウイルス不活化法とリアルタイムウイルス検出技術の開拓は、市場に革新的な機会をもたらします。異なるプラットフォーム間でのアッセイの標準化に向けた研究イニシアチブは、市場に大きな成長の可能性をもたらしています。

地域別の洞察

米国とカナダは、バイオマニュファクチャリングによるウイルス検出と定量化にとって極めて重要な市場です。これらの南北アメリカ地域は、先進的なヘルスケアシステム、一人当たりの医療費の高さ、生物製剤の安全性と有効性を管理する厳格な規制環境が特徴です。欧州諸国では、バイオ製造部門は技術革新、品質、安全性を重視し、先進的です。このEMEA地域の顧客は、EUの厳格な規制枠組みに沿った最先端のウイルス検出技術の採用に熱心です。中東は、ヘルスケア投資の増加とバイオ医薬品需要の高まりにより、有望な成長を示しています。中東地域のウイルス検出・定量化市場は、現地生産および輸入生物製剤の品質保証に対する消費者のニーズが高まっていることから、まだ始まったばかりです。アジア太平洋地域は、堅調な経済成長、ヘルスケア支出の増加、技術導入の拡大により、バイオマニュファクチャリング領域で急成長を遂げています。ウイルス検出・定量化ソリューションの需要は、APAC地域で急成長するワクチン生産部門と輸出市場によって牽引されており、顧客は費用対効果が高く信頼性の高い技術を選好しています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは、バイオマニュファクチャリングにおけるウイルス検出・定量化市場の評価において極めて重要です。事業戦略や製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、バイオマニュファクチャリングにおけるウイルス検出・定量化市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1-市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1-バイオマニュファクチャリングにおけるウイルス検出・定量化市場の市場規模および予測は？

2-バイオマニュファクチャリングにおけるウイルス検出・定量化市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3-バイオマニュファクチャリングにおけるウイルス検出・定量化市場における技術動向と規制の枠組みは？

4-バイオマニュファクチャリングにおけるウイルス検出・定量化市場における主要ベンダーの市場シェアは？

5-バイオマニュファクチャリングにおけるウイルス検出・定量化市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • ウイルス性疾患の発生率の増加と検出技術の強化の必要性
      • 医薬品の開発および製造プロセスへの指数関数的な投資
      • ポータブルかつポイントオブケアの重要検査に対する需要の高まり
    • 抑制要因
      • 熟練した人材の不足と定量化装置のコストの高さ
    • 機会
      • ウイルス検査および定量化手法の急速な進歩
      • ウイルス汚染物質の環境モニタリングに重点を置く
    • 課題
      • ウイルス量の分離に関連する技術的困難
  • 市場セグメンテーション分析
    • 製品タイプ：高精度のための消耗品の進歩
    • テクノロジー：高い特異性を実現するためのPCR技術の採用の改善
    • 用途：ワクチンおよび治療薬の製造における用途の急増
    • エンドユーザー：CROおよびCDMOによるウイルス定量化の採用の増加
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 バイオマニュファクチャリングにおけるウイルス検出・定量化市場オファリングタイプ別

  • 消耗品
    • アクセサリー
    • キットとアッセイ
  • 機器
  • サービス

第7章 バイオマニュファクチャリングにおけるウイルス検出・定量化市場：技術別

  • 酵素免疫測定法
  • フローサイトメトリー
  • プラークアッセイ
  • ポリメラーゼ連鎖反応

第8章 バイオマニュファクチャリングにおけるウイルス検出・定量化市場：用途別

  • 血液および血液製剤の製造
  • 細胞および遺伝子治療製品の製造
  • 幹細胞製品の製造
  • ティッシュおよびティッシュ製品の製造
  • ワクチンと治療薬の製造

第9章 バイオマニュファクチャリングにおけるウイルス検出・定量化市場：エンドユーザー別

  • CROとCDMO
  • ライフサイエンス企業
  • 試験所

第10章 南北アメリカのバイオマニュファクチャリングにおけるウイルス検出・定量化市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第11章 アジア太平洋地域のバイオマニュファクチャリングにおけるウイルス検出・定量化市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第12章 欧州・中東・アフリカのバイオマニュファクチャリングにおけるウイルス検出・定量化市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第13章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ主要企業別の分析
    • 新製品発売と機能強化
    • 受賞・表彰・拡大

第14章 競争力のあるポートフォリオ

  • 主要な企業プロファイル
    • Agilent Technologies, Inc.
    • BASF SE
    • Becton, Dickinson and Company
    • Bio-Rad Laboratories, Inc.
    • bioMerieux SA
    • Charles River Laboratories
    • Danaher Corporation
    • Genscript Biotech Corporation
    • Hamilton Company
    • Illumina, Inc.
    • LG Chem, Ltd.
    • Lonza Group Ltd.
    • Merck KGaA
    • New England Biolabs
    • Norgen Biotek Corp.
    • Oxford Nanopore Technologies PLC
    • PerkinElmer, Inc.
    • Promega Corporation
    • QIAGEN N.V.
    • Recipharm AB
    • Sartorius AG
    • Shimadzu Corporation
    • Takara Bio Inc.
    • Thermo Fisher Scientific Inc.
    • Thomas Scientific LLC
    • Zymo Research Corporation
  • 主要な製品ポートフォリオ

第15章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET RESEARCH PROCESS
  • FIGURE 2. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET DYNAMICS
  • FIGURE 7. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2023 VS 2030 (%)
  • FIGURE 8. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 10. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 12. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 14. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 24. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 8. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY KITS & ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 13. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY PLAQUE ASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 18. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY BLOOD & BLOOD PRODUCTS MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CELLULAR & GENE THERAPY PRODUCTS MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY STEM CELL PRODUCTS MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TISSUE & TISSUE PRODUCTS MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY VACCINES & THERAPEUTICS MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 24. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CROS & CDMOS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY LIFE SCIENCE COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TESTING LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 236. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 237. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 238. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET LICENSE & PRICING
目次
Product Code: MRR-5C6F41F5AFA5

[194 Pages Report] The Biomanufacturing Viral Detection & Quantification Market size was estimated at USD 2.67 billion in 2023 and expected to reach USD 2.89 billion in 2024, at a CAGR 8.40% to reach USD 4.71 billion by 2030.

Global Biomanufacturing Viral Detection & Quantification Market

KEY MARKET STATISTICS
Base Year [2023] USD 2.67 billion
Estimated Year [2024] USD 2.89 billion
Forecast Year [2030] USD 4.71 billion
CAGR (%) 8.4%
Biomanufacturing Viral Detection & Quantification Market - IMG1

The biomanufacturing viral detection and quantification market encompasses the industries and sectors involved in developing, producing, and commercializing technologies, services, and solutions for identifying and measuring viral contaminants in the biomanufacturing process. The increased investments in biopharmaceutical R&D is contributing to the market growth. The heightened awareness of product safety following high-profile contamination cases and the introduction of stringent regulatory requirements drive the business growth in the biomanufacturing viral detection & quantification market. However, the high costs of testing and the complexity of regulatory approval processes may create barriers to entry for smaller companies, affecting market competitiveness. The need for highly skilled individuals to perform and interpret complex assays adds to market space operational challenges. Moreover, developing novel viral inactivation methods and real-time viral detection technologies creates innovative opportunities in the market. The research initiative, which is directed towards standardizing assays across different platforms, creates significant growth potential in the market.

Regional Insights

In the Americas, the United States and Canada are pivotal markets for biomanufacturing viral detection and quantification. These Americas region is characterized by advanced healthcare systems, high per capita healthcare spending, and stringent regulatory environments that govern the safety and efficacy of biologics. In the European countries, the biomanufacturing sector is advanced with a strong emphasis on innovation, quality, and safety. Customers in this EMEA region are keen on adopting state-of-the-art viral detection technologies that align with the stringent EU regulatory frameworks. The Middle East shows promising growth with increased healthcare investments and a rising demand for biopharmaceuticals. The market for viral detection and quantification in the Middle East region is nascent, with a growing consumer need for quality assurance in locally produced and imported biologics. The Asia Pacific region is experiencing surge in the biomanufacturing domain, due to robust economic growth, increasing healthcare expenditures, and growing technological adoption. The demand for viral detection and quantification solutions is driven by the burgeoning vaccine production sector and export market in the APAC region, with customers showing a preference for cost-effective yet reliable technologies.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Biomanufacturing Viral Detection & Quantification Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Biomanufacturing Viral Detection & Quantification Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Biomanufacturing Viral Detection & Quantification Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., BASF SE, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., bioMerieux SA, Charles River Laboratories, Danaher Corporation, Genscript Biotech Corporation, Hamilton Company, Illumina, Inc., LG Chem, Ltd., Lonza Group Ltd., Merck KGaA, New England Biolabs, Norgen Biotek Corp., Oxford Nanopore Technologies PLC, PerkinElmer, Inc., Promega Corporation, QIAGEN N.V., Recipharm AB, Sartorius AG, Shimadzu Corporation, Takara Bio Inc., Thermo Fisher Scientific Inc., Thomas Scientific LLC, and Zymo Research Corporation.

Market Segmentation & Coverage

This research report categorizes the Biomanufacturing Viral Detection & Quantification Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Offering Type
    • Consumables
      • Accessories
      • Kits & Assays
    • Instruments
    • Services
  • Technology
    • Enzyme-Linked Immunosorbent Assay
    • Flow Cytometry
    • Plaque Assay
    • Polymerase Chain Reaction
  • Application
    • Blood & Blood Products Manufacturing
    • Cellular & Gene Therapy Products Manufacturing
    • Stem Cell Products Manufacturing
    • Tissue & Tissue Products Manufacturing
    • Vaccines & Therapeutics Manufacturing
  • End User
    • CROs & CDMOs
    • Life Science Companies
    • Testing Laboratories
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Biomanufacturing Viral Detection & Quantification Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Biomanufacturing Viral Detection & Quantification Market?

3. What are the technology trends and regulatory frameworks in the Biomanufacturing Viral Detection & Quantification Market?

4. What is the market share of the leading vendors in the Biomanufacturing Viral Detection & Quantification Market?

5. Which modes and strategic moves are suitable for entering the Biomanufacturing Viral Detection & Quantification Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Biomanufacturing Viral Detection & Quantification Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidence of viral diseases and need for enhanced detection techniques
      • 5.1.1.2. Exponential investments in drug development and manufacturing processes
      • 5.1.1.3. Growing demand for portable and point-of-care vital testing
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of skilled personnel and high cost of quantification devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Rapid advancements in viral testing and quantification methods
      • 5.1.3.2. Emphasis on environmental monitoring of viral contaminants
    • 5.1.4. Challenges
      • 5.1.4.1. Technical difficulties associated with the isolation of viral load
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Offering Type: Advances in consumables for high accuracy
    • 5.2.2. Technology: Improved adoption of PCR technique for high specificity
    • 5.2.3. Application: Surging applications in vaccines & therapeutics manufacturing
    • 5.2.4. End User: Rising adoption from CROs and CDMOs for viral quantification
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Biomanufacturing Viral Detection & Quantification Market, by Offering Type

  • 6.1. Introduction
  • 6.2. Consumables
    • 6.3.1. Accessories
    • 6.3.2. Kits & Assays
  • 6.3. Instruments
  • 6.4. Services

7. Biomanufacturing Viral Detection & Quantification Market, by Technology

  • 7.1. Introduction
  • 7.2. Enzyme-Linked Immunosorbent Assay
  • 7.3. Flow Cytometry
  • 7.4. Plaque Assay
  • 7.5. Polymerase Chain Reaction

8. Biomanufacturing Viral Detection & Quantification Market, by Application

  • 8.1. Introduction
  • 8.2. Blood & Blood Products Manufacturing
  • 8.3. Cellular & Gene Therapy Products Manufacturing
  • 8.4. Stem Cell Products Manufacturing
  • 8.5. Tissue & Tissue Products Manufacturing
  • 8.6. Vaccines & Therapeutics Manufacturing

9. Biomanufacturing Viral Detection & Quantification Market, by End User

  • 9.1. Introduction
  • 9.2. CROs & CDMOs
  • 9.3. Life Science Companies
  • 9.4. Testing Laboratories

10. Americas Biomanufacturing Viral Detection & Quantification Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Biomanufacturing Viral Detection & Quantification Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Biomanufacturing Viral Detection & Quantification Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player
    • 13.3.1. New Product Launch & Enhancement
      • 13.3.1.1. Launch of DNAllergen Real-time PCR Kits for the Reliable Detection Of Target Allergen Sequences
      • 13.3.1.2. Virax Biolabs Group Limited Introduces Avian Influenza A Virus Real-Time PCR Test Kit
    • 13.3.2. Award, Recognition, & Expansion
      • 13.3.2.1. New BGI Genomics Fluorescent RT-PCR Kit Approved for COVID-19, Influenza A & B Detection in Australia

14. Competitive Portfolio

  • 14.1. Key Company Profiles
    • 14.1.1. Agilent Technologies, Inc.
    • 14.1.2. BASF SE
    • 14.1.3. Becton, Dickinson and Company
    • 14.1.4. Bio-Rad Laboratories, Inc.
    • 14.1.5. bioMerieux SA
    • 14.1.6. Charles River Laboratories
    • 14.1.7. Danaher Corporation
    • 14.1.8. Genscript Biotech Corporation
    • 14.1.9. Hamilton Company
    • 14.1.10. Illumina, Inc.
    • 14.1.11. LG Chem, Ltd.
    • 14.1.12. Lonza Group Ltd.
    • 14.1.13. Merck KGaA
    • 14.1.14. New England Biolabs
    • 14.1.15. Norgen Biotek Corp.
    • 14.1.16. Oxford Nanopore Technologies PLC
    • 14.1.17. PerkinElmer, Inc.
    • 14.1.18. Promega Corporation
    • 14.1.19. QIAGEN N.V.
    • 14.1.20. Recipharm AB
    • 14.1.21. Sartorius AG
    • 14.1.22. Shimadzu Corporation
    • 14.1.23. Takara Bio Inc.
    • 14.1.24. Thermo Fisher Scientific Inc.
    • 14.1.25. Thomas Scientific LLC
    • 14.1.26. Zymo Research Corporation
  • 14.2. Key Product Portfolio

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing